Chimeric Therapeutics is trading 25% up at A$0.01, with no clear company-specific announcement or reliable reported catalyst identified for the September 30 move.
- The move comes at a very low share price, following recent closes fluctuating between A$0.00 and A$0.01.
- The latest filing found was an application to quote additional shares, dated September 22; it does not establish a reason for the move.